Health Canada publishes information about unauthorized synthetic peptides

Revision 1 · International public policy · Canada / international · Record prepared

Prepared through Iliyn’s AI-assisted editorial workflow. Source statements are not independent audits of underlying events.

Health Canada’s October 23 overview distinguishes authorized peptide medicines from unauthorized products promoted for human use.

What the record says

The agency says it has identified growing numbers of unauthorized peptide health products promoted and sold in Canada. The overview describes promotion through social media for wellness, appearance and performance purposes. It separately notes that some peptide drugs have authorized medical uses.

Source details and supporting locations.

Practical next step

Read the issuing agency’s full announcement for details and subsequent developments.

Limits and what is not established

This overview does not establish that every peptide product is unauthorized or that all products share identical risks. Patients should consult a healthcare professional and the complete regulatory guidance before using a product.

Sources checked October 24, 2026. Later notices may change instructions or arrangements.

Original sources

Health Canada: original information

Corrections and history

Read correction history

Analytics is off unless you choose to accept. Privacy and contact